An Observational Post-Marketing Safety Registry of Sativex®

Mise à jour : Il y a 4 ans
Référence : NCT02073474

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this registry is to monitor safety outcomes of patients who are receiving Sativex® for Multiple Sclerosis (MS) spasticity and for off-label indications in the United Kingdom (UK), Germany and Sweden.


Critère d'inclusion

  • Multiple sclerosis,diabetes,Cancer,neuropathic pain

Liens